Abstract
This brief review article describes the progress made in the synthesis of five- and six-membered heterocyclic rings by the application of the ring-closing metathesis reactions during the period of 2007-2008.
Keywords: Ring closing metathesis, synthesis of heterocycles, Grubbs 'catalyst, oxygen heterocycles, nitrogen heterocycles
Current Organic Synthesis
Title: Formation of Five- and Six-Membered Heterocyclic Compounds by Ringclosing Metathesis
Volume: 7 Issue: 2
Author(s): K. C. Majumdar, Buddhadeb Chattopadhyay and Krishanu Ray
Affiliation:
Keywords: Ring closing metathesis, synthesis of heterocycles, Grubbs 'catalyst, oxygen heterocycles, nitrogen heterocycles
Abstract: This brief review article describes the progress made in the synthesis of five- and six-membered heterocyclic rings by the application of the ring-closing metathesis reactions during the period of 2007-2008.
Export Options
About this article
Cite this article as:
Majumdar C. K., Chattopadhyay Buddhadeb and Ray Krishanu, Formation of Five- and Six-Membered Heterocyclic Compounds by Ringclosing Metathesis, Current Organic Synthesis 2010; 7 (2) . https://dx.doi.org/10.2174/157017910790820292
DOI https://dx.doi.org/10.2174/157017910790820292 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Canine Nutritional Model: Influence of Age, Diet, and Genetics on Health and Well-Being
Current Nutrition & Food Science Withdrawal Notice: Comparison of Pharmaceutical Effect of Alemtuzumab and Natalizumab and Their Side Effects in Treatment of Various Stages of Multiple Sclerosis Patients
CNS & Neurological Disorders - Drug Targets Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies
Recent Patents on Anti-Cancer Drug Discovery Synthesis and in vitro Evaluation of the Anticancer Potential of New Aminoalkanol Derivatives of Xanthone
Anti-Cancer Agents in Medicinal Chemistry Overview
Anti-Cancer Agents in Medicinal Chemistry Targeted Radionuclide Therapy - An Overview
Current Radiopharmaceuticals Polymeric Nanomicelles of Soluplus® as a Strategy for Enhancing the Solubility, Bioavailability and Efficacy of Poorly Soluble Active Compounds
Current Nanomedicine Ultrasound Enhances the Transfection of Plasmid DNA by Non-viral Vectors
Current Pharmaceutical Biotechnology Anti-HER2 Cancer Therapy and Cardiotoxicity
Current Pharmaceutical Design Impact of Antihypertensive Drug Use on Bone Mineral Density and Osteoporotic Fracture - From an Epidemiological Perspective
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Formulation and Evaluation of Resveratrol Loaded Cubosomal Nanoformulation for Topical Delivery
Current Drug Delivery HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Inflammatory Network
Inflammation & Allergy - Drug Targets (Discontinued) Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Current Pharmaceutical Design Follow the ATP: Tumor Energy Production: A Perspective
Anti-Cancer Agents in Medicinal Chemistry Extracellular HSP90: An Emerging Target for Cancer Therapy
Current Signal Transduction Therapy Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction
Current Pharmaceutical Design Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
Current Medicinal Chemistry WNT4 Signaling in Female Gonadal Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Microbicides for Prevention of Transmission of Sexually Transmitted Diseases
Current Pharmaceutical Design The Role of Cytokines in Pharmacological Modulation of Hepatic Ischemia/Reperfusion Injury
Current Pharmaceutical Design